InspireMD Other Operating Expenses vs Cost Of Revenue Analysis

NSPR Stock

USD 2.00 0.01 0.50%

InspireMD financial indicator trend analysis is infinitely more than just investigating InspireMD recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether InspireMD is a good investment. Please check the relationship between InspireMD Other Operating Expenses and its Cost Of Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

Other Operating Expenses vs Cost Of Revenue

Other Operating Expenses vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of InspireMD Other Operating Expenses account and Cost Of Revenue. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between InspireMD's Other Operating Expenses and Cost Of Revenue is 0.45. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of InspireMD, assuming nothing else is changed. The correlation between historical values of InspireMD's Other Operating Expenses and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of InspireMD are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Other Operating Expenses i.e., InspireMD's Other Operating Expenses and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.45

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of InspireMD. It is also known as InspireMD overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on InspireMD income statement and represents the costs associated with goods and services InspireMD provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from InspireMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into InspireMD current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.At this time, InspireMD's Tax Provision is relatively stable compared to the past year. As of 05/05/2024, Sales General And Administrative To Revenue is likely to grow to 2.31, while Issuance Of Capital Stock is likely to drop slightly above 27.4 M.

	2021	2022	2023	2024 (projected)
Cost Of Revenue	3.7M	4.1M	4.4M	3.1M
Research Development	5.2M	7.8M	8.0M	4.3M

Cost Of Revenue Research Development

InspireMD fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Property Plant And Equipment Gross	Short Term Debt	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable
Total Assets		0.59	0.11	0.97	-0.57	-0.57	0.34	0.97	0.18	0.92	0.49	0.08	1.0	-0.35	-0.12	0.64	0.17	0.26	0.05	0.26	0.88	-0.28	0.61	0.82	-0.36	0.21
Other Current Liab	0.59		0.43	0.48	-0.1	-0.26	0.29	0.51	0.42	0.5	0.35	0.49	0.58	-0.08	0.23	0.79	0.47	0.4	0.38	0.68	0.54	-0.15	0.58	0.59	-0.03	0.25
Total Current Liabilities	0.11	0.43		-0.07	0.43	-0.1	0.02	0.14	-0.21	0.12	0.11	0.7	0.11	-0.48	0.7	0.37	0.52	0.01	0.46	0.22	0.09	0.78	0.27	0.05	0.15	0.43
Total Stockholder Equity	0.97	0.48	-0.07		-0.66	-0.63	0.27	0.96	0.15	0.91	0.56	-0.14	0.97	-0.34	-0.33	0.58	-0.01	0.22	-0.13	0.17	0.89	-0.4	0.61	0.83	-0.45	0.14
Net Debt	-0.57	-0.1	0.43	-0.66		0.47	-0.57	-0.64	-0.13	-0.43	-0.49	0.36	-0.59	0.1	0.46	-0.37	-0.03	-0.29	0.07	0.01	-0.46	0.58	-0.42	-0.47	0.53	-0.17
Retained Earnings	-0.57	-0.26	-0.1	-0.63	0.47		0.12	-0.68	0.35	-0.65	-0.94	0.35	-0.55	0.67	0.42	-0.66	0.03	0.29	0.27	0.3	-0.74	0.06	-0.85	-0.79	0.91	0.01
Cash	0.34	0.29	0.02	0.27	-0.57	0.12		0.33	0.26	0.03	-0.04	0.45	0.37	0.05	0.36	0.27	0.49	0.41	0.55	0.26	0.02	-0.24	0.12	0.02	0.05	0.49
Cash And Short Term Investments	0.97	0.51	0.14	0.96	-0.64	-0.68	0.33		0.04	0.9	0.6	0.02	0.97	-0.47	-0.14	0.68	0.23	0.26	0.08	0.14	0.87	-0.21	0.68	0.8	-0.49	0.28
Common Stock Total Equity	0.18	0.42	-0.21	0.15	-0.13	0.35	0.26	0.04		0.0	-0.26	0.13	0.17	0.6	-0.08	0.16	0.08	0.54	0.12	0.81	0.05	-0.46	-0.1	0.15	0.44	0.01
Common Stock Shares Outstanding	0.92	0.5	0.12	0.91	-0.43	-0.65	0.03	0.9	0.0		0.52	-0.05	0.91	-0.37	-0.21	0.55	0.01	0.11	-0.11	0.17	0.97	-0.18	0.56	0.83	-0.41	0.06
Other Stockholder Equity	0.49	0.35	0.11	0.56	-0.49	-0.94	-0.04	0.6	-0.26	0.52		-0.34	0.47	-0.65	-0.45	0.72	0.01	-0.18	-0.25	-0.2	0.61	-0.12	0.91	0.71	-0.86	0.07
Total Liab	0.08	0.49	0.7	-0.14	0.36	0.35	0.45	0.02	0.13	-0.05	-0.34		0.1	0.0	0.95	0.25	0.76	0.28	0.85	0.42	-0.09	0.45	-0.03	-0.14	0.45	0.46
Total Current Assets	1.0	0.58	0.11	0.97	-0.59	-0.55	0.37	0.97	0.17	0.91	0.47	0.1		-0.35	-0.09	0.62	0.18	0.29	0.08	0.25	0.86	-0.28	0.59	0.79	-0.34	0.26
Common Stock	-0.35	-0.08	-0.48	-0.34	0.1	0.67	0.05	-0.47	0.6	-0.37	-0.65	0.0	-0.35		-0.02	-0.41	-0.07	0.33	0.09	0.46	-0.35	-0.42	-0.6	-0.38	0.56	-0.26
Short Long Term Debt Total	-0.12	0.23	0.7	-0.33	0.46	0.42	0.36	-0.14	-0.08	-0.21	-0.45	0.95	-0.09	-0.02		0.03	0.69	0.14	0.82	0.21	-0.27	0.6	-0.2	-0.34	0.48	0.45
Non Current Assets Total	0.64	0.79	0.37	0.58	-0.37	-0.66	0.27	0.68	0.16	0.55	0.72	0.25	0.62	-0.41	0.03		0.52	0.27	0.33	0.32	0.67	-0.09	0.87	0.79	-0.49	0.28
Non Currrent Assets Other	0.17	0.47	0.52	-0.01	-0.03	0.03	0.49	0.23	0.08	0.01	0.01	0.76	0.18	-0.07	0.69	0.52		0.45	0.95	0.31	0.03	0.31	0.28	0.04	0.04	0.48
Net Receivables	0.26	0.4	0.01	0.22	-0.29	0.29	0.41	0.26	0.54	0.11	-0.18	0.28	0.29	0.33	0.14	0.27	0.45		0.49	0.71	0.08	-0.35	-0.09	0.05	0.41	0.53
Non Current Liabilities Total	0.05	0.38	0.46	-0.13	0.07	0.27	0.55	0.08	0.12	-0.11	-0.25	0.85	0.08	0.09	0.82	0.33	0.95	0.49		0.35	-0.11	0.27	0.01	-0.13	0.26	0.51
Inventory	0.26	0.68	0.22	0.17	0.01	0.3	0.26	0.14	0.81	0.17	-0.2	0.42	0.25	0.46	0.21	0.32	0.31	0.71	0.35		0.18	-0.22	-0.04	0.17	0.52	0.3
Property Plant And Equipment Gross	0.88	0.54	0.09	0.89	-0.46	-0.74	0.02	0.87	0.05	0.97	0.61	-0.09	0.86	-0.35	-0.27	0.67	0.03	0.08	-0.11	0.18		-0.22	0.66	0.93	-0.51	0.0
Short Term Debt	-0.28	-0.15	0.78	-0.4	0.58	0.06	-0.24	-0.21	-0.46	-0.18	-0.12	0.45	-0.28	-0.42	0.6	-0.09	0.31	-0.35	0.27	-0.22	-0.22		-0.02	-0.3	0.14	0.07
Other Liab	0.61	0.58	0.27	0.61	-0.42	-0.85	0.12	0.68	-0.1	0.56	0.91	-0.03	0.59	-0.6	-0.2	0.87	0.28	-0.09	0.01	-0.04	0.66	-0.02		0.78	-0.73	0.05
Property Plant And Equipment Net	0.82	0.59	0.05	0.83	-0.47	-0.79	0.02	0.8	0.15	0.83	0.71	-0.14	0.79	-0.38	-0.34	0.79	0.04	0.05	-0.13	0.17	0.93	-0.3	0.78		-0.59	-0.05
Current Deferred Revenue	-0.36	-0.03	0.15	-0.45	0.53	0.91	0.05	-0.49	0.44	-0.41	-0.86	0.45	-0.34	0.56	0.48	-0.49	0.04	0.41	0.26	0.52	-0.51	0.14	-0.73	-0.59		0.12
Accounts Payable	0.21	0.25	0.43	0.14	-0.17	0.01	0.49	0.28	0.01	0.06	0.07	0.46	0.26	-0.26	0.45	0.28	0.48	0.53	0.51	0.3	0.0	0.07	0.05	-0.05	0.12

Click cells to compare fundamentals

InspireMD Account Relationship Matchups

InspireMD fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.9M	17.8M	39.7M	24.7M	47.6M	50.0M
Other Current Liab	2.1M	3.1M	3.0M	4.0M	4.5M	2.7M
Total Current Liabilities	3.1M	3.7M	4.3M	5.1M	6.0M	4.2M
Total Stockholder Equity	5.4M	12.2M	33.5M	17.4M	39.5M	41.5M
Net Debt	(4.9M)	(11.6M)	(10.8M)	(3.0M)	(9.6M)	(9.2M)
Retained Earnings	(157.6M)	(168.2M)	(183.1M)	(201.6M)	(221.5M)	(210.4M)
Cash	5.5M	12.6M	12.0M	4.6M	9.6M	7.6M
Cash And Short Term Investments	5.5M	12.6M	34.0M	17.8M	39.0M	41.0M
Common Stock Shares Outstanding	139.3K	1.5M	7.3M	7.9M	24.3M	25.5M
Liabilities And Stockholders Equity	9.9M	17.8M	39.7M	24.7M	47.6M	50.0M
Other Stockholder Equity	163.0M	180.3M	216.6M	219.0M	261M	138.1M
Total Liab	4.5M	5.6M	6.2M	7.3M	8.1M	6.9M
Total Current Assets	7.8M	15.3M	37.1M	21.3M	44.2M	46.4M
Non Current Assets Total	2.1M	2.4M	2.6M	3.3M	3.5M	2.0M
Non Currrent Assets Other	586K	725K	905K	856K	951K	654.2K
Net Receivables	973K	945K	1.4M	1.2M	1.8M	1.0M
Non Current Liabilities Total	1.4M	1.9M	1.8M	2.2M	2.1M	2.1M
Inventory	1.2M	1.4M	1.1M	1.6M	2.1M	1.2M
Property Plant And Equipment Gross	421K	1.5M	1.7M	2.5M	4.6M	4.8M
Other Liab	729K	910K	1.1M	995K	1.1M	738.6K
Property Plant And Equipment Net	421K	1.5M	1.7M	2.5M	2.5M	2.7M
Accounts Payable	646K	236K	893K	659K	939K	570.7K
Other Assets	586K	725K	905K	856K	984.4K	506K
Retained Earnings Total Equity	(140.4M)	(147.6M)	(157.6M)	(168.2M)	(151.4M)	(158.9M)
Other Current Assets	87K	334K	522K	15.1M	3.0M	1.6M
Property Plant Equipment	547K	448K	1.7M	2.5M	2.8M	3.0M
Net Tangible Assets	5.4M	12.2M	33.5M	17.4M	20.0M	21.0M
Capital Surpluse	143.1M	156.4M	163.0M	180.3M	207.4M	157.7M
Non Current Liabilities Other	624K	605K	1.4M	1.9M	2.2M	2.3M
Net Invested Capital	5.4M	12.2M	33.5M	17.4M	39.5M	41.5M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards InspireMD in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, InspireMD's short interest history, or implied volatility extrapolated from InspireMD options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether InspireMD is a strong investment it is important to analyze InspireMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact InspireMD's future performance. For an informed investment choice regarding InspireMD Stock, refer to the following important reports:

How To Invest In InspireMD

Details

Is InspireMD Stock a good investment?

Details

What is InspireMD's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for InspireMD Stock analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.

	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences

Is InspireMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InspireMD. If investors know InspireMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InspireMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.82)

Revenue Per Share

0.256

Quarterly Revenue Growth

0.716

Return On Assets

(0.37)

Return On Equity

(0.70)

The market value of InspireMD is measured differently than its book value, which is the value of InspireMD that is recorded on the company's balance sheet. Investors also form their own opinion of InspireMD's value that differs from its market value or its book value, called intrinsic value, which is InspireMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InspireMD's market value can be influenced by many factors that don't directly affect InspireMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between InspireMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if InspireMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InspireMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

InspireMD Other Operating Expenses vs Cost Of Revenue Analysis

Other Operating Expenses vs Cost Of Revenue

Other Operating Expenses vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Other Operating Expenses

Cost Of Revenue

InspireMD fundamental ratios Correlations

InspireMD Account Relationship Matchups

High Positive Relationship

High Negative Relationship

InspireMD fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for InspireMD Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Stockholder Equity	+ 0.97	Total Assets
Cash And Short Term Investments	+ 0.97	Total Assets
Total Current Assets	+ 0.97	Total Stockholder Equity
Total Current Assets	+ 0.97	Cash And Short Term Investments
Property Plant And Equipment Gross	+ 0.97	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.94	Retained Earnings
Current Deferred Revenue	- 0.86	Other Stockholder Equity
Other Liab	- 0.85	Retained Earnings
Property Plant And Equipment Net	- 0.79	Retained Earnings
Property Plant And Equipment Gross	- 0.74	Retained Earnings
Current Deferred Revenue	- 0.73	Other Liab